If you're between the ages of 28 and 43, then get ready to go down memory lane because you're about to be hit with a strong ...

GSK’s Trelegy, a treatment for chronic obstructive pulmonary disease (COPD), aimed to address a gap in the market with its ...

EXCLUSIVE: After scoring his eighth Grammy nomination for comedy album The Prisoner, Jim Gaffigan has unveiled the trailer for The Skinny, his new special coming to Hulu on November 22, which will be ...

Calm's 30-second TV spot that ran against Election Night programming was praised by viewers and strategists for its ...

Controversial transgender-focused commercials resonated with key voter groups, and the Harris campaign failed to respond.

Former President Donald Trump is lashing out against Fox News for allegedly attempting to "change and weaken" his 2024 presidential campaign commercials. On Monday, Trump complained in a post to ...

Film and TV productions have slowly dripped out of Los Angeles in recent years to other markets offering generous incentive programs, but California Gov. Gavin Newsom has a plan to re-energize the ...

in combination with Keytruda, Merck’s anti-PD-1 therapy, as adjuvant treatment for patients with resectable Stage II, IIIA or IIIB non-small cell lung cancer who did not achieve a pathological ...

The INTerpath-009 trial will investigate an individualized neoantigen therapy plus Keytruda in patients with non-small cell lung cancer post-surgery whose disease didn't fully respond to prior ...

NEW YORK – Moderna and Merck will test their personalized neoantigen cancer vaccine V940 with Merck's checkpoint inhibitor Keytruda (pembrolizumab) in certain non-small cell lung cancer patients in a ...

KEYTRUDA plus chemotherapy is the first approval in the EU for an anti-PD-1 therapy combined with chemotherapy only for patients with primary advanced or recurrent endometrial carcinoma regardless ...